The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Trek thanks for the reply, glad to see you are doing well. I'm somewhat behind you! I retired at the end of March and then immediately got Covid 19, for my sins, in the midst of the first peak so was wiped out till mid May. Dabbling a bit (as a retirement project) before then but not really paying attention until then, as I was either working or Covidised. So I'm only a few months in, but I'm around 50% up since then so can't complain, but these are arm-band style levels of ££ so hardly life changing. My plan is to factor-up the investment chunks once my arm-bands can come off, and gain a more serious non-pension-fund-originated income from 2021 which will be the fun fund, if you know what I mean.
Hi Hypermarlin,
Yes I think I have around 20 stocks atm 6 are on free carries now and the carries are significantly up. TXP has been life changing for me along with several covid stocks from Jan/Feb.
TBH I haven’t look into the distribution. I registered as a sales lead just to get company news. If it’s listed you get RNS but unlisted companies don’t do that. The market has pretty much written the potential tester orders off here. It’s as good a risk as you will find and the email pretty much shows how quickly they have moved on.
Atb
Trek
hello Trek, I remember you from ARGO, I think, back in the spring/summer. I didn't have the pateince for that and departed evens, eventually. Seen you around in AVCT too, and other places! Question, if you know - I'm aware of KeyOptions as the Virolens distributor for various geographies, esp in Apac and Latam (your contact Rick Wylie, I note, runs KeyOptions and appears to be based in Australia [https://www.linkedin.com/in/rwylie/]. Do you know who has distribution for UK/Europe/USA, I could not find this (or am looking in the wrong places/cannot read etc?!)?
I think they will pull this off and it sits well with cruise ships, offices, schools, gyms etc. TTG will benefit from orders.
If they get FDA that’ll be huge and we now from the spurt to 270 and drop to 200p that the tester is not yet in the sp.
I added 2449 shares. Pity I can’t get my holdings into an ISA!
Trek
Part 2
“Virolens® Production release availability
We are already receiving significant interest in the system, and are approaching our first run limits. Machines are allocated on a first come, first served order basis and we expect to see the first production run start in late October.
If you are interested in purchasing, we would appreciate a forecast of what your purchase requirements are, pending necessary approvals. We are also establishing escrow funds as an option for customers that will guarantee their orders once they start to roll off the production line. That would mean committing funds to an escrow account and them being released on manufacture availability.
The entire KeyOptions team is very excited to help bring this product to market and help solve a global catastrophe.
Regards,
KeyOptions - Virolens® team”
Trek
Part 1
Email from Rick Wylie,
“As you have expressed interest in the groundbreaking Virolens® system, we wish to provide you a status update.
Pre-Production Systems
Pre-Production has now commenced and we currently have limited pre-production systems available for purchase. These systems are available for testing and certification at a cost of USD$39,000 + freight charges and excluding any local taxes.
Each system includes the following:
1 x Virolens® testing machine
1 x Artificial Intelligence gateway
1,000 x Test cartridges
The package is available for early adopters and organisations that need to do further testing. As the solution is a pre-production system, the Virolens® machine will be replaced by the developer, with a full production system when they become available in early November.
The pre-production systems are selling fast, so please let us know if you are interested.
Certifications & Trials
Once the first Virolens® machine commences production release in the coming weeks, the CE marking and MHRA approvals will be awarded to the machine. Once this milestone is achieved, we will be fast tracking other local country approvals. The FDA approval is currently in process.”